nach oben

Reactions Weekly

Erschienen in:

01.11.2021 | Case report

Pembrolizumab

Transient primary hypothyroidism, hepato-pancreatitis, and hypophysitis manifesting as isolated corticotropin deficiency: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Treatment drug considered "prednisone" based on table 1.

Oguz SH, et al. Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: A new case and literature review. Immunotherapy 13: 1157-1163, No. 14, Oct 2021. Available from: URL: http://doi.org/10.2217/imt-2021-0061CrossRef

Titel: Pembrolizumab
Transient primary hypothyroidism, hepato-pancreatitis, and hypophysitis manifesting as isolated corticotropin deficiency: case report
Publikationsdatum: 01.11.2021
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-05154-0

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Pembrolizumab

Transient primary hypothyroidism, hepato-pancreatitis, and hypophysitis manifesting as isolated corticotropin deficiency: case report

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Cyclophosphamide/etoposide

Multiple drugs

Pasireotide

Dapsone

Dexamethasone

Nitrous-oxide abuse